Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingling Dai

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|September 5, 2024
Yangzheng mixture reversed EMT against hepatocellular carcinoma metastasis via NF-κB/NLRP3/β-catenin pathwayZhengyan Gong, Xuemei Wang, Yuhong Li, et al.
Environment & Health (Washington, D.C.)|November 27, 2025
MeP Induces Metabolic Disorder and Liver Damage at Human-Relevant Exposure Levels: Role of the Gut MicrobiotaHenglin Zhang, Yanan Zhao, Haitao Tu, et al.
Cancer Letters|May 20, 2021
WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2/Stat3 and Wnt/β-catenin signalingTianfeng Yang, Rui Xu, Jian Huo, et al.
Clinical and Translational Medicine|September 29, 2021
Selenium sulfide disrupts the PLAGL2/C-MET/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinomaTianfeng Yang, Jian Huo, Rui Xu, et al.
Heliyon|September 8, 2023
Role of NLRP3 inflammasome activation in HCC cell progressionBingling Dai, Hanbing Cao, Yu Hu, et al.
Journal of Cellular and Molecular Medicine|February 18, 2020
Sanguinarine disrupts the colocalization and interaction of HIF-1α with tyrosine and serine phosphorylated-STAT3 in breast cancerQi Su, Jingjing Wang, Mengying Fan, et al.
Cells|March 6, 2021
A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human LymphoblastsTianxia Li, Bo Ning, Lingbo Kong, et al.
Pharmacological Research|May 15, 2020
Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent mannerMan Zhu, Xianpeng Shi, Zhengyan Gong, et al.
Journal of Advanced Research|June 4, 2023
Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loopWenjuan Tang, Yu Hu, Kaihui Tu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 18, 2022
Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cellsBingling Dai, Mengying Fan, Xiaoyue Huang, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Toxicon : Official Journal of the International Society on Toxinology|September 5, 2024
Yangzheng mixture reversed EMT against hepatocellular carcinoma metastasis via NF-κB/NLRP3/β-catenin pathwayZhengyan Gong, Xuemei Wang, Yuhong Li, et al.
Environment & Health (Washington, D.C.)|November 27, 2025
MeP Induces Metabolic Disorder and Liver Damage at Human-Relevant Exposure Levels: Role of the Gut MicrobiotaHenglin Zhang, Yanan Zhao, Haitao Tu, et al.
Cancer Letters|May 20, 2021
WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2/Stat3 and Wnt/β-catenin signalingTianfeng Yang, Rui Xu, Jian Huo, et al.
Clinical and Translational Medicine|September 29, 2021
Selenium sulfide disrupts the PLAGL2/C-MET/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinomaTianfeng Yang, Jian Huo, Rui Xu, et al.
Heliyon|September 8, 2023
Role of NLRP3 inflammasome activation in HCC cell progressionBingling Dai, Hanbing Cao, Yu Hu, et al.
Journal of Cellular and Molecular Medicine|February 18, 2020
Sanguinarine disrupts the colocalization and interaction of HIF-1α with tyrosine and serine phosphorylated-STAT3 in breast cancerQi Su, Jingjing Wang, Mengying Fan, et al.
Cells|March 6, 2021
A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human LymphoblastsTianxia Li, Bo Ning, Lingbo Kong, et al.
Pharmacological Research|May 15, 2020
Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent mannerMan Zhu, Xianpeng Shi, Zhengyan Gong, et al.
Journal of Advanced Research|June 4, 2023
Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loopWenjuan Tang, Yu Hu, Kaihui Tu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 18, 2022
Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cellsBingling Dai, Mengying Fan, Xiaoyue Huang, et al.
Pageof 6